Pharma companies are by definition firms that turn human capital into financial capital. They have to hire new scientists and managers, sales people etc in order to scale.

AI now and increasingly in the future lowers the cost/value of human capital.

Therefore Pharmaceutical output will be driven by AI inasmuch as it’s currently driven by talent and human capital.

Caveat: current pharma companies that do not rely on human capital for growth may not be disrupted and will likely benefit.